Reset filter

Working with the media

ANZCA has an experienced communications team that proactively engages with the media to highlight the important work of our anaesthetists and pain specialists. This includes sharing our latest evidence-based research and patient safety initiatives. We also actively encourage m...

Find out more

About the ANZCA Clinical Trials Network

Our clinical trials seek definitive answers to inform best practice and improve patient care and safety. Explore who we are; our strategic priorities; our history and funding achievements; major findings from our published trials; and important research questions underway.

Find out more

Smoking and anaesthesia factsheet

Pain-medicine-stories-by-the-ABC-and-The-Age-joint-winners-of-ANZCA-Media-Award-28-Feb-2019

ANZCA Pholcodine Statement September 2023

Recall of pholcodine - Pholcodine Statement

ANZCA Pholcodine Statement September 2023

This statement has been prepared in response to the decision of the Australian Government Therapeutic Goods Administration (TGA) to withdraw pholcodine-containing products from the market. Evidence shows that pholcodine consumption in the 12-month period prior to a general an...

PS40(G)BP Position statement on relationship between fellows, trainees and healthcare industry BP

PS40(G)BP Position statement on the relationship between fellows, trainees and the healthcare industry Background Paper

Latest PoM Communiqué

CPD Appendix 17 CPD Plan

PoM communique October2019

First  < Prev   ... 21 22 23 24 25 26 27 28 29    Next >  Last Pages: 21 of 29